Intellia Therapeutics
+$2.71 (+3.18%) Today
+$1.32 (+1.50%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell NTLA and other stocks, options, and ETFs commission-free!
About NTLA
Intellia Therapeutics, Inc. Common Stock, also called Intellia Therapeutics, is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system.
CEO
John M. Leonard
Employees
312
Headquarters
Cambridge, Massachusetts
Founded
2014
NTLA Key Statistics
Market Cap
6.00B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.26M
High Today
$89.26
Low Today
$84.21
Open Price
$84.21
Volume
1.74M
52 Week High
$92.00
52 Week Low
$16.54
Analyst Ratings
80%
of 15 ratings
Buy
80%
Hold
20%
Sell
0%
NTLA Earnings
-$0.69
-$0.46
-$0.23
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, Pre-Market